A TikTok from a doctor tagged with GLP-1, diabetes and obesity topics. No caption details on what the clip covers.
Recap by typeshit. Video by @mad_endo on TikTok.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
18:51
A doctor walks through four of the most talked about weight loss drugs in one overview, covering the big names people ask about most.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
The market research firm credits insurance coverage with lifting uptake in Canada, though it gives no Canadian figures. It also says the Wegovy pill passed 3m US prescriptions in about five months.
The International Association of Trichologists says the review saw promise in short peptides for hair follicles, but most remain unproven.
Loading…